Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease [Phase 2]
Phase 2A study of GM 608 in mild to moderate Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-08Clinical Trial Update: A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients [Phase 3]
Phase 3 trial update assessing safety and efficacy of a gastric-retentive formulation (AP-CD/LD) in advanced Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes [Phase 3]
Phase 3 clinical trial results for CVT-301 in Parkinson's disease patients with OFF episodes have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Telemedicine Intervention to Improve Cognitive Function [NA]
A completed clinical trial investigated a telemedicine intervention to improve cognitive function in individuals with Parkinson's disease, w…
-
CLINICAL_TRIALS trial_result · 2019-07-23Clinical Trial Update: Evaluation of the Efficacy and Safety of Bumetanide in Parkinson's Disease [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of bumetanide in Parkinson's disease is ongoing with unknown status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods. [Phase 2, Phase 3]
Clinical trial update for apomorphine nasal powder in Parkinson's disease focusing on 'off' periods, spanning Phase 2 and Phase 3 and comple…
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease [Phase 3]
Phase 3 clinical trial update for subcutaneous apomorphine infusion in advanced Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease [Phase 4]
Phase 4 trial evaluating the efficacy and safety of agomelatine in patients with Parkinson's disease and depression.
-
CLINICAL_TRIALS trial_result · 2019-05-22Clinical Trial Update: Modulation of Gut Microbiota by Rifaximin in PD Patients [Phase 1, Phase 2]
Early-phase clinical trial update evaluating rifaximin to modulate gut microbiota in Parkinson's disease patients with inflammatory consider…
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease [Phase 2]
Phase 2 trial assessing repeated-dose oral N-acetylcysteine for treating Parkinson's disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease [Phase 2]
Phase 2 trial investigating safety and efficacy of NTCELL immunoprotected porcine choroid plexus cells for xenotransplantation in Parkinson'…
-
CLINICAL_TRIALS trial_result · 2019-05-08Clinical Trial Update: Mirabegron in Parkinson Disease and Impaired Cognition [Phase 4]
Phase 4 clinical trial update on mirabegron in Parkinson disease and impaired cognition with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease. [Phase 3]
Phase 3 trial update on safety and tolerability of tozadenant as adjunctive therapy in levodopa-treated patients with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: The Effects of Dual Task Training in Individuals With Parkinson's Disease [NA]
A completed clinical trial studying the effects of dual task training in individuals with Parkinson's disease; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants [Phase 3]
A completed Phase 3 study evaluating TVP-1012 (1 mg) in levodopa-treated Parkinson's disease patients; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Short Pulse Width DBS in Parkinson's Disease [Phase 2]
Phase 2 clinical trial update evaluating short pulse width deep brain stimulation in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease [Phase 2]
A Phase 2 trial evaluating topiramate as an adjunct to amantadine for dyskinesia in Parkinson's disease was terminated; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome [Phase 2]
Phase 2 clinical trial evaluating brain imaging with nuclear technology in individuals with Parkinson's disease and Parkinsonian syndrome co…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID [Phase 3]
Phase 3 trial evaluating amantadine hydrogen chloride ER tablets in Parkinson's disease patients with Levodopa-induced dyskinesia was termin…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID. [Phase 3]
Phase 3 trial of extended-release amantadine HCl for Parkinson's disease with levodopa-induced dyskinesias was terminated; results posted in…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms [Phase 4]
Phase 4 trial update evaluating short-term Motilitone therapy effects on quality of life in Parkinson disease patients with gastrointestinal…
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: Prism Adaptation Treatment of Parkinson's Disease [NA]
A completed clinical trial investigating prism adaptation treatment for Parkinson's disease, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Impact of Walking Practice on Persons With PD [NA]
Clinical trial update on walking practice for people with Parkinson's disease; terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease [Phase 4]
Phase 4 trial comparing DA-9701 with domperidone in Parkinson's disease to evaluate therapeutic efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease [Phase 2]
Phase 2 clinical trial update examining nilotinib's safety, tolerability, pharmacokinetics, and biomarkers in Parkinson's disease and Parkin…